Abstract 855: p53 isoform Ä133p53â triple negative breast cancer and increased relapse with neoadjuvant taxanes

Jean-christophe Bourdon; Alexandra Diot; Valerie Meuray; Leen Slaets; Richard Iggo; Herve Bonnefoi; David Cameron; Alastair M. Thompson

doi:10.1158/1538-7445.AM2016-855

Abstract 855: p53 isoform Ä133p53â triple negative breast cancer and increased relapse with neoadjuvant taxanes

Jean-christophe Bourdon, Alexandra Diot, Valerie Meuray, Leen Slaets, Richard Iggo, Herve Bonnefoi, David Cameron, Alastair M. Thompson

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	855-855
Journal	Cancer Research
Volume	76
Issue number	14 Supplement
DOIs	https://doi.org/10.1158/1538-7445.AM2016-855
Publication status	Published - 15 Jul 2016

Access to Document

10.1158/1538-7445.AM2016-855

http://cancerres.aacrjournals.org/lookup/doi/10.1158/1538-7445.AM2016-855

Cite this

@article{abdd57dbc3504cffa59e090ac46d4b54,

title = "Abstract 855: p53 isoform {\"A}133p53{\^a} triple negative breast cancer and increased relapse with neoadjuvant taxanes",

author = "Jean-christophe Bourdon and Alexandra Diot and Valerie Meuray and Leen Slaets and Richard Iggo and Herve Bonnefoi and David Cameron and Thompson, {Alastair M.}",

year = "2016",

month = jul,

day = "15",

doi = "10.1158/1538-7445.AM2016-855",

language = "English",

volume = "76",

pages = "855--855",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "14 Supplement",

}

TY - JOUR

T1 - Abstract 855: p53 isoform Ä133p53â triple negative breast cancer and increased relapse with neoadjuvant taxanes

AU - Bourdon, Jean-christophe

AU - Diot, Alexandra

AU - Meuray, Valerie

AU - Slaets, Leen

AU - Iggo, Richard

AU - Bonnefoi, Herve

AU - Cameron, David

AU - Thompson, Alastair M.

PY - 2016/7/15

Y1 - 2016/7/15

U2 - 10.1158/1538-7445.AM2016-855

DO - 10.1158/1538-7445.AM2016-855

M3 - Meeting abstract

SN - 0008-5472

VL - 76

SP - 855

EP - 855

JO - Cancer Research

JF - Cancer Research

IS - 14 Supplement

ER -